01529nas a2200361   4500000000100000008004100001260001300042653001700055653001100072653001100083653002500094653000900119653001600128653002100144653002500165653002200190653002800212653002200240100001200262700001300274700001500287700001600302700001200318700002400330700001400354700001400368245007800382856005100460300001100511490000700522520062400529022001401153       2010                            d  c2010 Sep10aBone Cements10aBrazil10aHumans10aLeprosy, Tuberculoid10aMale10aMiddle Aged10aMuscular Atrophy10aMycobacterium leprae10aPeripheral nerves10aPolymethyl Methacrylate10aTreatment Outcome1 aOrsi AT1 aSantos M1 aMiranda AE1 aBandeira CO1 aSilva L1 aChrusciak-Talhari A1 aTalhari C1 aTalhari S00aHand atrophy in a leprosy patient--treatment with polymethylmethacrylate.  uhttps://leprosyreview.org/article/81/3/21-6220  a216-200 v813 a<p>Leprosy, an infectious disease caused by Mycobacterium leprae, affects mostly the skin and peripheral nerves. The polymethylmethacrylate has been used as bone cement, knee and intraocular implants as a bioexpansor, filling the area where it is applied. We describe the case of a Brazilian male with tuberculoid leprosy who developed muscular wasting between the metacarpals of both hands. Ten years after leprosy treatment, he was submitted to five applications of 10% polymethylmethacrylate. The treatment was successful, improving the appearance of his hands leading to a positive impact on the patient's life.</p>  a0305-7518